<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01851486</url>
  </required_header>
  <id_info>
    <org_study_id>0393-12-RMB.CTIL</org_study_id>
    <nct_id>NCT01851486</nct_id>
  </id_info>
  <brief_title>The Relationships Between the Noradrenergic, Opioid and Pain System</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The role of alpha2 receptor agonist on pain perception and modulation will be examined. In
      addition whether this is mediated through the opioid system will be examined. Pain perception
      and modulation will be examined before and after administration of Clonidine or placebo
      together with Naloxone or saline.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Labortory focus was changed and study was not opened at all
  </why_stopped>
  <start_date type="Actual">January 2013</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The changes in pain responses after administration of alpha 2 agonist and mu receptor antagonist</measure>
    <time_frame>2 years</time_frame>
    <description>The change in pain perception (pain thresholds and pain ratings of suprathresholds stimuli) and in the excitatory and inhibitory pain modulation responses (assessed by the temporal summation and conditioned pain modulation paradigms) will be examined before and after administration of alpha 2 agonist with and without mu receptor antagonist</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Experimental Pain Perception</condition>
  <arm_group>
    <arm_group_label>Clonidine+ Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clonidine 0.15 mg and saline 0.15 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clonidine + Naloxone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clonidine 0.15 mg and Naloxone 0.15 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo +Naloxone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo 0.15 mg+ naloxone 0.15 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo +saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 0.15 mg+ saline 0.15 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>Clonidine 0.15 mg</description>
    <arm_group_label>Clonidine+ Saline</arm_group_label>
    <arm_group_label>Clonidine + Naloxone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naloxone</intervention_name>
    <description>naloxone 0.15 mg/kg</description>
    <arm_group_label>Clonidine + Naloxone</arm_group_label>
    <arm_group_label>Placebo +Naloxone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo +Naloxone</arm_group_label>
    <arm_group_label>Placebo +saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline</intervention_name>
    <arm_group_label>Clonidine+ Saline</arm_group_label>
    <arm_group_label>Placebo +saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

          -  Age 18-40

          -  No chronic disease

        Exclusion Criteria:

          -  Subjects who suffer from chronic pain / pain syndrome

          -  use of anti-depressant or anti-psychotic drugs

          -  suffering from cardiovascular disease

          -  breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2013</study_first_submitted>
  <study_first_submitted_qc>May 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2013</study_first_posted>
  <last_update_submitted>October 1, 2017</last_update_submitted>
  <last_update_submitted_qc>October 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>d_yarnitsky</investigator_full_name>
    <investigator_title>Professor, Head on Neurology Department</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naloxone</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

